Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Nicola Normanno
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Living Beings
Physiology
Anatomy
Sign-in to see full Profile
Network (preview)
37
Salomon, David
25
Bianco, Caterina
25
Ciardiello, Fortunato
23
De Luca, Antonella
17
Maiello, Monica
16
Strizzi, Luigi
14
Mancino, Mario
9
Sanicola, Michele
9
Wechselberger, Christian
8
Perrone, Francesco
7
Campiglio, Manuela
7
Bianco, Angelo Raffaele
7
Sun, Youping
6
Casamassimi, Amelia
6
Di Maio, Massimo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Nicola Normanno (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Mancino Mario; Esposito Claudia; Watanabe Kazuhide; Nagaoka Tadahiro; Gonzales Monica; Bianco Caterina; Normanno Nicola; Salomon David S; Strizzi Luigi
Neuronal guidance protein Netrin-1 induces differentiation in human embryonal carcinoma cells.
Cancer research 2009;69(5):1717-21.
-
2008: Cirillo Donatella; Rachiglio Anna Maria; la Montagna Raffaele; Giordano Antonio; Normanno Nicola
Leptin signaling in breast cancer: an overview.
Journal of cellular biochemistry 2008;105(4):956-64.
-
2008: Normanno Nicola; Campiglio Manuela; Maiello Monica R; De Luca Antonella; Mancino Mario; Gallo Marianna; D'Alessio Amelia; Menard Sylvie
Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling.
Breast cancer research and treatment 2008;112(1):25-33.
-
2008: Zampa Germano; Moscato Michele; Brannigan Brian W; Morabito Alessandro; Bell Daphne W; Normanno Nicola
Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinib.
Lung cancer (Amsterdam, Netherlands) 2008;60(3):452-4.
-
2008: Garfield David; Cadranel Jacques; Normanno Nicola
Osteoblastic metastases in non-small cell lung cancer and its possible significance.
Lung cancer (Amsterdam, Netherlands) 2008;60(1):146-7.
-
2008: Mancino Mario; Strizzi Luigi; Wechselberger Christian; Watanabe Kazuhide; Gonzales Monica; Hamada Shin; Normanno Nicola; Salomon David S; Bianco Caterina
Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
Journal of cellular physiology 2008;215(1):192-203.
-
2008: De Luca Antonella; Carotenuto Adele; Rachiglio Annamaria; Gallo Marianna; Maiello Monica R; Aldinucci Donatella; Pinto Antonio; Normanno Nicola
The role of the EGFR signaling in tumor microenvironment.
Journal of cellular physiology 2008;214(3):559-67.
-
2008: Bianco Caterina; Strizzi Luigi; Mancino Mario; Watanabe Kazuhide; Gonzales Monica; Hamada Shin; Raafat Ahmed; Sahlah Lawson; Chang Cindy; Sotgia Federica; Normanno Nicola; Lisanti Michael; Salomon David S
Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
The American journal of pathology 2008;172(2):345-57.
-
2007: Ottaiano A; Budillon A; Normanno N; Iaffaioli V R; Caraglia M
A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):960-1.
-
2007: Maiello Monica R; D'Alessio Amelia; De Luca Antonella; Carotenuto Adele; Rachiglio Anna Maria; Napolitano Maria; Cito Letizia; Guzzo Antonella; Normanno Nicola
AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.
Breast cancer research and treatment 2007;102(3):275-82.
-
2007: Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert A D; D'Antonio A; Losito S; Normanno N; Salomon D S
Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
The Journal of pathology 2007;211(1):36-44.
-
2006: Bianco Caterina; Strizzi Luigi; Mancino Mario; Rehman Aasia; Hamada Shin; Watanabe Kazuhide; De Luca Antonella; Jones Brenda; Balogh Gabriela; Russo Jose; Mailo Daniel; Palaia Raffaele; D'Aiuto Giuseppe; Botti Gerardo; Perrone Francesco; Salomon David S; Normanno Nicola
Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5158-64.
-
2006: Morabito Alessandro; De Maio Ermelinda; Di Maio Massimo; Normanno Nicola; Perrone Francesco
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions.
The oncologist 2006;11(7):753-64.
-
2006: Morabito A; Di Maio M; De Maio E; Normanno N; Perrone F
Methodology of clinical trials with new molecular-targeted agents: where do we stand?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii128-31.
-
2006: Normanno Nicola; De Luca Antonella; Maiello Monica R; Campiglio Manuela; Napolitano Maria; Mancino Mario; Carotenuto Adele; Viglietto Giuseppe; Menard Sylvie
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Journal of cellular physiology 2006;207(2):420-7.
-
2006: Normanno Nicola; Gullick William J
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
Endocrine-related cancer 2006;13(1):3-6.
-
2006: Normanno Nicola; De Luca Antonella; Bianco Caterina; Strizzi Luigi; Mancino Mario; Maiello Monica R; Carotenuto Adele; De Feo Gianfranco; Caponigro Francesco; Salomon David S
Epidermal growth factor receptor (EGFR) signaling in cancer.
Gene 2006;366(1):2-16.
-
2005: Normanno Nicola; Di Maio Massimo; De Maio Ermelinda; De Luca Antonella; de Matteis Andrea; Giordano Antonio; Perrone Francesco;
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.
Endocrine-related cancer 2005;12(4):721-47.
-
2005: Di Maio Massimo; Gridelli Cesare; Normanno Nicola; Perrone Francesco; Ciardiello Fortunato
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Journal of cellular physiology 2005;205(3):355-63.
-
2005: Normanno Nicola; De Luca Antonella; Maiello Monica R; Gridelli Cesare
Modulation of epidermal growth factor receptor-positive circulating tumor cells by chemotherapy in non-small-cell lung cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7746-8; author reply 7748.
-
2005: Strizzi Luigi; Bianco Caterina; Raafat Ahmed; Abdallah Wissam; Chang Cindy; Raafat Dina; Hirota Morihisa; Hamada Shin; Sun Youping; Normanno Nicola; Callahan Robert; Hinck Lindsay; Salomon David
Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
Journal of cell science 2005;118(Pt 20):4633-43.
-
2005: Normanno N; Campiglio M; Perrone F; De Luca A; Menard S
Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1709.
-
2005: Strizzi Luigi; Bianco Caterina; Normanno Nicola; Salomon David
Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Oncogene 2005;24(37):5731-41.
-
2005: Normanno N; De Luca A; Aldinucci D; Maiello M R; Mancino M; D'Antonio A; De Filippi R; Pinto A
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis.
Endocrine-related cancer 2005;12(2):471-82.
-
2005: Wechselberger Christian; Strizzi Luigi; Kenney Nicholas; Hirota Morihisa; Sun Youping; Ebert Andreas; Orozco Olivia; Bianco Caterina; Khan Nadia I; Wallace-Jones Brenda; Normanno Nicola; Adkins Heather; Sanicola Michele; Salomon David S
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
Oncogene 2005;24(25):4094-105.
-
2005: Normanno N; Bianco C; Strizzi L; Mancino M; Maiello M R; De Luca A; Caponigro F; Salomon D S
The ErbB receptors and their ligands in cancer: an overview.
Current drug targets 2005;6(3):243-57.
-
2005: Caponigro Francesco; Formato Roberta; Caraglia Michele; Normanno Nicola; Iaffaioli Rosario Vincenzo
Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors.
Current opinion in oncology 2005;17(3):212-7.
-
2005: Perrone Francesco; Di Maio Massimo; Budillon Alfredo; Normanno Nicola
Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trials.
Current opinion in oncology 2005;17(2):123-9.
-
2005: Caponigro Francesco; Basile Maria; de Rosa Vincenzo; Normanno Nicola
New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
Anti-cancer drugs 2005;16(2):211-21.
-
2005: Bianco Caterina; Strizzi Luigi; Ebert Andreas; Chang Cindy; Rehman Aasia; Normanno Nicola; Guedez Liliana; Salloum Rita; Ginsburg Erika; Sun Youping; Khan Nadia; Hirota Morihisa; Wallace-Jones Brenda; Wechselberger Christian; Vonderhaar Barbara K; Tosato Giovanna; Stetler-Stevenson William G; Sanicola Michele; Salomon David S
Role of human cripto-1 in tumor angiogenesis.
Journal of the National Cancer Institute 2005;97(2):132-41.
-
2005: Normanno Nicola; De Luca Antonella; Maiello Monica R; Mancino Mario; D'Antonio Antonio; Macaluso Marcella; Caponigro Francesco; Giordano Antonio
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in breast cancer: current status and future development.
Frontiers in bioscience : a journal and virtual library 2005;10():2611-7.
-
2005: Bianco Caterina; Strizzi Luigi; Normanno Nicola; Khan Nadia; Salomon David S
Cripto-1: an oncofetal gene with many faces.
Current topics in developmental biology 2005;67():85-133.
-
2004: Normanno N; Maiello M R; Mancino M; De Luca A
Small molecule epidermal growth factor receptor tyrosine kinase inhibitors: an overview.
Journal of chemotherapy (Florence, Italy) 2004;16 Suppl 4():36-40.
-
2004: Strizzi Luigi; Bianco Caterina; Normanno Nicola; Seno Masaharu; Wechselberger Christian; Wallace-Jones Brenda; Khan Nadia I; Hirota Morihisa; Sun Youping; Sanicola Michele; Salomon David S
Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Journal of cellular physiology 2004;201(2):266-76.
-
2004: Normanno Nicola; De Luca Antonella; Maiello Monica R; Bianco Caterina; Mancino Mario; Strizzi Luigi; Arra Claudio; Ciardiello Fortunato; Agrawal Sudhir; Salomon David S
CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.
International journal of oncology 2004;25(4):1013-20.
-
2004: Bianco Caterina; Normanno Nicola; Salomon David S; Ciardiello Fortunato
Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
Growth factors (Chur, Switzerland) 2004;22(3):133-9.
-
2004: De Luca Antonella; Grassii Michele; Maiello Monica R; Di Maio Massimo; Mancino Mario; De Maio Ermelinda; Gridelli Cesare; Perrone Francesco; Normanno Nicola
Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?
Anticancer research 2004;24(5A):2985-9.
-
2004: Normanno Nicola; Di Maio Massimo; Perrone Francesco; Campiglio Manuela
Molecular markers to predict response to gefitinib: EGFR, ErbB-2, or more?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):2035-6; author reply 2036-7.
-
2004: Campiglio Manuela; Normanno Nicola; Ménard Sylvie
Re: Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
Journal of the National Cancer Institute 2004;96(9):715; author reply 715-6.
-
2004: Campiglio Manuela; Locatelli Alberta; Olgiati Clelia; Normanno Nicola; Somenzi Giulia; Viganò Lucia; Fumagalli Marzia; Ménard Sylvie; Gianni Luca
Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level.
Journal of cellular physiology 2004;198(2):259-68.
-
2004: Normanno Nicola; De Luca Antonella; Bianco Caterina; Maiello Monica R; Carriero Maria V; Rehman Aasia; Wechselberger Christian; Arra Claudio; Strizzi Luigi; Sanicola Michele; Salomon David S
Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
Journal of cellular physiology 2004;198(1):31-9.
-
2003: Pinto Antonio; De Filippi Rosaria; Frigeri Ferdinando; Corazzelli Gaetano; Normanno Nicola
Aging and the hemopoietic system.
Critical reviews in oncology/hematology 2003;48(Suppl):S3-S12.
-
2003: Adkins Heather B; Bianco Caterina; Schiffer Susan G; Rayhorn Paul; Zafari Mohammad; Cheung Anne E; Orozco Olivia; Olson Dian; De Luca Antonella; Chen Ling Ling; Miatkowski Konrad; Benjamin Chris; Normanno Nicola; Williams Kevin P; Jarpe Matthew; LePage Doreen; Salomon David; Sanicola Michele
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
The Journal of clinical investigation 2003;112(4):575-87.
-
2003: Normanno N; Bianco C; De Luca A; Maiello M R; Salomon D S
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
Endocrine-related cancer 2003;10(1):1-21.
-
2003: Bianco Caterina; Strizzi Luigi; Rehman Aasia; Normanno Nicola; Wechselberger Christian; Sun Youping; Khan Nadia; Hirota Morihisa; Adkins Heather; Williams Kevin; Margolis Richard U; Sanicola Michele; Salomon David S
A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
Cancer research 2003;63(6):1192-7.
-
2003: Normanno Nicola; Maiello Monica R; De Luca Antonella
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?
Journal of cellular physiology 2003;194(1):13-9.
-
2002: D'Antonio Antonio; Losito Simona; Pignata Sandro; Grassi Michele; Perrone Francesco; De Luca Antonella; Tambaro Rosa; Bianco Caterina; Gullick William J; Johnson Gibbes R; Iaffaioli Vincenzo R; Salomon David S; Normanno Nicola
Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
International journal of oncology 2002;21(5):941-8.
-
2002: Bianco Caterina; Adkins Heather B; Wechselberger Christian; Seno Masaharu; Normanno Nicola; De Luca Antonella; Sun Youping; Khan Nadia; Kenney Nicholas; Ebert Andreas; Williams Kevin P; Sanicola Michele; Salomon David S
Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Molecular and cellular biology 2002;22(8):2586-97.
-
2002: Normanno N; Campiglio M; De Luca A; Somenzi G; Maiello M; Ciardiello F; Gianni L; Salomon D S; Menard S
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):65-72.
-
2002: Bianco Caterina; Normanno Nicola; De Luca Antonella; Maiello Monica Rosaria; Wechselberger Christian; Sun Youping; Khan Nadia; Adkins Heather; Sanicola Michele; Vonderhaar Barbara; Cohen Bruce; Seno Masaharu; Salomon David
Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
Journal of cellular physiology 2002;190(1):74-82.
-
2001: Normanno N; Bianco C; De Luca A; Salomon D S
The role of EGF-related peptides in tumor growth.
Frontiers in bioscience : a journal and virtual library 2001;6():D685-707.
-
2000: Saloman D S; Bianco C; Ebert A D; Khan N I; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick W J; Persico G
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
Endocrine-related cancer 2000;7(4):199-226.
-
2000: De Luca A; Arra C; D'Antonio A; Casamassimi A; Losito S; Ferraro P; Ciardiello F; Salomon D S; Normanno N
Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.
Oncogene 2000;19(51):5863-71.
-
2000: De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1439-44.
-
2000: Casamassimi A; De Luca A; Agrawal S; Stromberg K; Salomon D S; Normanno N
EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):319-25.
-
1999: Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco A R; Ciardiello F
Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
Oncology reports 1999;6(5):1105-9.
-
1999: De Angelis E; Grassi M; Gullick W J; Johnson G R; Rossi G B; Tempesta A; De Angelis F; De Luca A; Salomon D S; Normanno N
Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families.
International journal of oncology 1999;14(3):437-40.
-
1999: De Luca A; Casamassimi A; Selvam M P; Losito S; Ciardiello F; Agrawal S; Salomon D S; Normanno N
EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells.
International journal of cancer. Journal international du cancer 1999;80(4):589-94.
-
1998: Normanno N; De Luca A; Castaldo A; Casamassimi A; Di Popolo A; Zarrilli R; Porcellini A; Acquaviva A M; Avvedimento V E; Pignata S
Apolipoprotein A-I reverse transcriptase-polymerase chain reaction analysis for detection of hematogenous colon cancer dissemination.
International journal of oncology 1998;13(3):443-7.
-
1998: Normanno N; De Luca A; Salomon D S; Ciardiello F
Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.
Cancer detection and prevention 1998;22(1):62-7.
-
1997: De Luca A; Selvam M P; Sandomenico C; Pepe S; Bianco A R; Ciardiello F; Salomon D S; Normanno N
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
International journal of cancer. Journal international du cancer 1997;73(2):277-82.
-
1997: Normanno N; Ciardiello F
EGF-related peptides in the pathophysiology of the mammary gland.
Journal of mammary gland biology and neoplasia 1997;2(2):143-51.
-
1997: Kannan S; De Santis M; Lohmeyer M; Riese D J; Smith G H; Hynes N; Seno M; Brandt R; Bianco C; Persico G; Kenney N; Normanno N; Martinez-Lacaci I; Ciardiello F; Stern D F; Gullick W J; Salomon D S
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells.
The Journal of biological chemistry 1997;272(6):3330-5.
-
1996: Normanno N; Bianco C; Damiano V; de Angelis E; Selvam M P; Grassi M; Magliulo G; Tortora G; Bianco A R; Mendelsohn J; Salomon D S; Ciardiello F
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):601-9.
-
1996: Mincione G; Bianco C; Kannan S; Colletta G; Ciardiello F; Sliwkowski M; Yarden Y; Normanno N; Pramaggiore A; Kim N; Salomon D S
Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells.
Journal of cellular biochemistry 1996;60(4):437-46.
-
1995: Normanno N; Kim N; Wen D; Smith K; Harris A L; Plowman G; Colletta G; Ciardiello F; Salomon D S
Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas.
Breast cancer research and treatment 1995;35(3):293-7.
-
1995: Normanno N; Selvam M P; Bianco C; Damiano V; de Angelis E; Grassi M; Magliulo G; Tortora G; Salomon D S; Ciardiello F
Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line.
International journal of cancer. Journal international du cancer 1995;62(6):762-6.
-
1995: Salomon D S; Brandt R; Ciardiello F; Normanno N
Epidermal growth factor-related peptides and their receptors in human malignancies.
Critical reviews in oncology/hematology 1995;19(3):183-232.
-
1995: Salomon D S; Normanno N; Ciardiello F; Brandt R; Shoyab M; Todaro G J
The role of amphiregulin in breast cancer.
Breast cancer research and treatment 1995;33(2):103-14.
-
1994: Brandt R; Normanno N; Gullick W J; Lin J H; Harkins R; Schneider D; Jones B W; Ciardiello F; Persico M G; Armenante F
Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.
The Journal of biological chemistry 1994;269(25):17320-8.
-
1994: Qi C F; Liscia D S; Normanno N; Merlo G; Johnson G R; Gullick W J; Ciardiello F; Saeki T; Brandt R; Kim N
Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
British journal of cancer 1994;69(5):903-10.
-
1994: Normanno N; Selvam M P; Qi C F; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R
Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2790-4.
-
1994: Ciardiello F; Tortora G; Bianco C; Selvam M P; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico M G
Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
Oncogene 1994;9(1):291-8.
-
1994: Normanno N; Ciardiello F; Brandt R; Salomon D S
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.
Breast cancer research and treatment 1994;29(1):11-27.
-
1993: Kenney N J; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin M B; Normanno N; Ciardiello F; Day A; Cutler M L
Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
Journal of cellular physiology 1993;156(3):497-514.
-
1993: Ciardiello F; Bianco C; Normanno N; Baldassarre G; Pepe S; Tortora G; Bianco A R; Salomon D S
Infection with a transforming growth factor alpha anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line.
International journal of cancer. Journal international du cancer 1993;54(6):952-8.
-
1992: Saeki T; Stromberg K; Qi C F; Gullick W J; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson G R; Salomon D S
Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
Cancer research 1992;52(12):3467-73.
-
1992: Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1992;34(4):272-8.
-
1992: Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson R B; Bianco A R; Salomon D S
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Molecular carcinogenesis 1992;6(1):43-52.
-
1991: Saeki T; Cristiano A; Lynch M J; Brattain M; Kim N; Normanno N; Kenney N; Ciardiello F; Salomon D S
Regulation by estrogen through the 5'-flanking region of the transforming growth factor alpha gene.
Molecular endocrinology (Baltimore, Md.) 1991;5(12):1955-63.
-
1991: Scala S; Pacelli R; Iaffaioli R V; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco A R
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Cancer research 1991;51(18):4898-902.
-
1991: Budillon A; Tagliaferri P; Caraglia M; Torrisi M R; Normanno N; Iacobelli S; Palmieri G; Stoppelli M P; Frati L; Bianco A R
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
Cancer research 1991;51(4):1294-9.
Sign-in to see more
